A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Clinical trial NCT05585281 · UNKNOWN
Trial details
- NCT number
- NCT05585281
- Sponsor
- Yongpeng Wang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2025-11-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.